公开(公告)号：GB2568986B

公开(公告)日：2019-12-18

申请号：GB201807590

申请日：2018-05-10

Applicant: HOWARD FOUNDATION HOLDINGS LTD

Inventor： ALAN NORMAN HOWARD ,  JOHN NOLAN ,  RIONA MULCAHY

IPC: A61K31/07 ,  A61K31/202 ,  A61K35/60 ,  A61P25/28

Abstract: A method for the prevention and/or treatment of dementia in a human subject; the method comprising the step of administering an effective amount of a composition comprising at least one carotenoid selected from the group consisting of lutein, zeaxanthin and meso-zeaxanthin; and a composition comprising at least one omega-3 fatty acid.

公开(公告)号：GB2568986A

公开(公告)日：2019-06-05

申请号：GB201807590

申请日：2018-05-10

Applicant: HOWARD FOUNDATION HOLDINGS LTD

Inventor： ALAN NORMAN HOWARD ,  JOHN NOLAN ,  RIONA MULCAHY

IPC: A61K31/07 ,  A61K31/202 ,  A61K35/60 ,  A61P25/28

Abstract: A composition comprising at least one carotenoid selected from the group consisting of lutein, zeaxanthin and meso-zeaxanthin; and a composition comprising at least one omega-3 fatty acid; for use in the prevention and/or treatment of dementia in a human subject is provided. The omega-3 fatty acid is preferably docosahexaenoic acid (DHA). A further omega-3 fatty acid, preferably eicosapentaenoic acid (EPA) may be present. The omega-3 fatty acid is preferably provided as a component of fish oil. The composition comprising at least one carotenoid may contain each of lutein, zeaxanthin and meso-zeaxanthin. The compositions may be formulated for oral consumption, preferably in the form of a capsule or tablet. The form of dementia is preferably Alzheimer’s disease.